Not provided
Not provided
Not provided
Not provided
undefined
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Treatment of macular edema secondary to central retinal vein occlusion is more effective with combined therapy of bevacizumab and triamcinolone than bevacizumab alone.
Comparison of two groups with different treatment with registrations of outcome in BCVA and complications
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bevacizumab and triamcinolone | Drug | three applications monthly administrated of bevacizumab 2.5mg for group 1 and bevacizumab 2.5 mg + triamcinolone 4mg first dose followed by two of bevacizumab alone for the group 2 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Best corrected visual acuity and macular edema measured with OCT | Follow up to 3 , 6 and 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Report treatment complications | 12 month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carmen Gonzalez-Mijares, Physician | Asociación para Evitar la Ceguera en México | Principal Investigator |
| Hugo Quiroz-Mercado, Retinologyst | Asociación para Evitar la Ceguera en México | Study Director |
| Juan Manuel Jimenez Sierra, Retinologyst | Asociación para Evitar la Ceguera en México | Study Chair |
| MA Martinez-Castellanos, Physician | Asociación para Evitar la Ceguera en México | Study Chair |
| Octavio Burgos Vejar, Physician | Asociación para Evitar la Ceguera en México | Study Chair |
| Raul Velez-Montoya, Physician | Asociación para Evitar la Ceguera en México | Study Chair |
| Ma de Lourdes Lopez Ramos, Physician | Asociación para Evitar la Ceguera en México | Study Chair |
| Omar Honerlager, preresident | Asociación para Evitar la Ceguera en México | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Asociacion Para Evitar la Ceguera en Mexico | Mexico City | Coyoacan | 04030 | Mexico |
Not provided
| ID | Term |
|---|---|
| D008269 | Macular Edema |
| D012170 | Retinal Vein Occlusion |
| ID | Term |
|---|---|
| D008268 | Macular Degeneration |
| D012162 | Retinal Degeneration |
| D012164 | Retinal Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068258 | Bevacizumab |
| D014221 | Triamcinolone |
| ID | Term |
|---|---|
| D061067 | Antibodies, Monoclonal, Humanized |
| D000911 | Antibodies, Monoclonal |
| D000906 | Antibodies |
| D007136 | Immunoglobulins |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D020246 |
| Venous Thrombosis |
| D013927 | Thrombosis |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D007162 |
| Immunoproteins |
| D001798 | Blood Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D012712 | Serum Globulins |
| D005916 | Globulins |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |